Codes and practices
Novo Nordisk is in full compliance with the Danish Corporate Governance Recommendations, and is - as a foreign listed issuer - in general in compliance with the corporate governance standards on New York and London Stock Exchanges where the Novo Nordisk B shares/ADRs are listed.
For a detailed review of Novo Nordisk's compliance with and deviations from the applicable codes please see the following:
- Nørby Committee recommendations (2005) - Copenhagen Stock Exchange
- Corporate Governance Standards (2004) - New York Stock Exchange
- The Combined Code (2006) - London Stock Exchange
This page has been assessed by PricewaterhouseCoopers as part of its assessment of Novo Nordisk’s statement that it reports ‘in accordance’ with GRI. Please refer to Audit and assurance for a full description of the nature of assurance offered.
